Article

Successful treatment of HCV-related cryoglobulinemic glomerulonephritis with double-filtration plasmapheresis and interferon combination therapy.

Osaka Rosai Hospital, Sakai, Japan.
Clinical and Experimental Nephrology (impact factor: 1.37). 05/2010; 14(4):372-6. DOI:10.1007/s10157-010-0282-3 pp.372-6
Source: PubMed

ABSTRACT A 67-year-old, hepatitis C virus (HCV)-positive woman was admitted to our hospital because of proteinuria and leg edema. Laboratory examination showed decreased serum albumin and complement activity and positive cryoglobulin. The HCV RNA genotype was 1b with high viral load. Kidney biopsy showed membranoproliferative glomerulonephritis (MPGN) with capillary deposition of C3, IgM, and IgG, indicating HCV-associated glomerulonephritis. In addition to interferon (IFN) therapy, double-filtration plasmapheresis (DFPP) was performed to reduce HCV RNA blood levels in the early stage of IFN therapy. This treatment greatly reduced the viral load and induced clinical remission of MPGN, suggesting that DFPP plus IFN combination therapy may represent a potentially effective modality for refractory-type HCV-associated glomerulonephritis.

0 0
 · 
0 Bookmarks
 · 
28 Views

Keywords

double-filtration plasmapheresis
 
effective modality
 
HCV RNA blood levels
 
HCV RNA genotype
 
HCV)-positive woman
 
HCV-associated glomerulonephritis
 
hepatitis C virus
 
IFN
 
IFN combination therapy
 
IFN therapy
 
IgM
 
induced clinical remission
 
Kidney biopsy
 
Laboratory examination
 
leg edema
 
membranoproliferative glomerulonephritis
 
MPGN
 
refractory-type HCV-associated glomerulonephritis
 
serum albumin
 

Tomoko Namba